Cargando…
Building the house of CARDS by phenotyping on the fly
Using clinical, pathophysiological and immunological phenotyping of ARDS to refine management of COVID-19 is urgently required to improve outcomes from refractory hypoxia https://bit.ly/2VvZe1p
Autor principal: | Rajendram, Rajkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450144/ https://www.ncbi.nlm.nih.gov/pubmed/32616600 http://dx.doi.org/10.1183/13993003.02429-2020 |
Ejemplares similares
-
COVID-19 phenotypes: leading or misleading?
por: Gattinoni, Luciano, et al.
Publicado: (2020) -
Response to COVID-19 phenotyping correspondence
por: Bos, Lieuwe D.J., et al.
Publicado: (2020) -
Instability of sputum molecular phenotypes in U-BIOPRED severe asthma
por: Kermani, Nazanin Z., et al.
Publicado: (2021) -
The effect of catch-up growth in the first year of life on later wheezing phenotypes
por: Kotecha, Sarah J., et al.
Publicado: (2020) -
Ivacaftor modifies cystic fibrosis neutrophil phenotype in subjects with R117H residual function CFTR mutations
por: Hardisty, Gareth R., et al.
Publicado: (2021)